Welcome

Welcome to the 'Oxford Innovative Organic Synthesis for Cancer Research (OxIOSCR)' project, an EU-funded Marie Curie Innovative Doctoral Programme (IDP), established to train graduate organic chemists to develop synthetic routes to natural products and their analogues with potent anti-cancer activity.
Chemistry equipment
Thirteen doctoral research students, Early Stage Researchers (ESRs), have begun a three-year comprehensive training programme, working within the Department of Chemistry at the University of Oxford, using state-of-the-art synthetic methods and techniques with a particular focus on biocatalysis, electrosynthesis and flow chemistry. The ESRs are working in teams of three or four on distinct programmes of research supported by expert chemistry and cancer biology advisers. While largely being based within Oxford's research environment, the ESRs, during their second year of training, will be posted on two one-month secondments hosted by eight Associated Partners distributed over six European countries.

The overarching aim of the OxIOSCR training programme is to lead to more sustainable synthetic chemistry, new strategies for organic synthesis, a strongly connected network of chemists and cancer biologists and release a generation of fully trained synthesis innovators into the academic and chemical industrial workplace.

Recent highlights

World Cancer Day - tours of the CRL (4th February 2016): World Cancer Day visitors - welcome to the OxIOSCR website! News and resources from the event. Read more...
AP news (Jan 2016). Nominations welcome for the 7th Prous Institute - Overton and Meyer Award for New Technologies in Drug Discovery... Read more...
Outreach - Sept 2015: Christian Kuper returns to his school in Germany to inspire the next generation of scientists. Read more...
Conference 2015: Dr Jason King, CEO, Oxford Biotrans joins us to speak (open Dept. colloquium) at the OxIOSCR conference on 23rd...Agenda...
Stacks Image 1536
This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement number: 316955.